Company Filing History:
1 out of 43 
1 out of 15,502 
1 out of 214 
Years Active: 2015-2019
Title: The Innovations of Saw-See Hong
Introduction
Saw-See Hong is a notable inventor based in Lyons, France. He has made significant contributions to the field of gene therapy, particularly through his innovative patents. With a total of 2 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
One of his latest patents is titled "Puma protein expression vector and use thereof in gene therapy." This invention relates to a viral vector designed for the expression of the cell death-inducing PUMA protein, which can be utilized in gene therapy for conditions such as rheumatoid arthritis. The vector comprises a recombinant adenovirus that expresses the gene encoding the PUMA protein, along with a recombinant baculovirus containing a coxsackie-adenovirus receptor (CAR). Another significant patent is focused on "Derivatives of 3-O-(3',3'-dimethylsuccinyl)-betulinic acid." This invention pertains to specific compounds that hold promise for various applications.
Career Highlights
Throughout his career, Saw-See Hong has worked with esteemed organizations such as Hospices Civils De Lyon and the University of California. His experience in these institutions has allowed him to develop and refine his innovative ideas.
Collaborations
He has collaborated with notable professionals in his field, including Pierre Miossec and Gary S. Firestein. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Saw-See Hong's contributions to gene therapy through his patents demonstrate his commitment to innovation in the medical field. His work continues to pave the way for future advancements in treatment options.